Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

Vaccines based on mRNA and viral vectors are currently used in the frontline to combat the ongoing pandemic caused by the novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). However, there is still an urgent need for alternative vaccine technologies inducing/boosting long-lasting and...

Full description

Bibliographic Details
Main Authors: Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn, Vesna Blazevic
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vaccines
Subjects:
VP6
Online Access:https://www.mdpi.com/2076-393X/9/7/733